Get notified when CAMP files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Going Concern (new) — The auditor's report includes a going-concern warning, indicating substantial doubt about the company's ability to continue operating.
Camp4 Therapeutics files to sell up to $100M of common stock at market prices; shares last at $3.80
Filed December 1, 2025 · ~2 min read
Key Changes
-
high
Camp4 is offering up to $100 million of common stock in an at-the-market program, with proceeds to the company.
The Offering verify on EDGAR → -
high
The offering is primary only; no selling stockholders are participating, so all net proceeds go to Camp4.
The Offering verify on EDGAR → -
medium
Net proceeds are earmarked for general corporate purposes, including R&D and clinical development, with no specific allocation determined.
Use of Proceeds verify on EDGAR →
4 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (CBRL 10-K) is open in full — no account needed.
Partner
Trade CAMP commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify